Chips are down as Manchester makes protein scanning breakthrough

August 25, 2008

Scientists at The University of Manchester have developed a new and fast method for making biological 'chips' - technology that could lead to quick testing for serious diseases, fast detection of MRSA infections and rapid discovery of new drugs.

Researchers working at the Manchester Interdisciplinary Biocentre (MIB) and The School of Chemistry have unveiled a new technique for producing functional 'protein chips' in a paper in the Journal of the American Chemical Society (JACS), published online today (22 August 2008).

Protein chips - or 'protein arrays' as they are more commonly known - are objects such as slides that have proteins attached to them and allow important scientific data about the behaviour of proteins to be gathered.

Functional protein arrays could give scientists the ability to run tests on tens of thousands of different proteins simultaneously, observing how they interact with cells, other proteins, DNA and drugs.

As proteins can be placed and located precisely on a 'chip', it would be possible to scan large numbers of them at the same time but then isolate the data relating to individual proteins.

These chips would allow large amounts of data to be generated with the minimum use of materials - especially rare proteins that are only available in very small amounts.

The Manchester team of Dr Lu Shin Wong, Dr Jenny Thirlway and Prof Jason Micklefield say the technical challenges of attaching proteins in a reliable way have previously held back the widespread application and development of protein chips.

Existing techniques for attaching proteins often results in them becoming fixed in random orientations, which can cause them to become damaged and inactive.

Current methods also require proteins to be purified first - and this means that creating large and powerful protein arrays would be hugely costly in terms of time, manpower and money.

Now researchers at The University of Manchester say they have found a reliable new way of attaching active proteins to a chip.

Biological chemists have engineered modified proteins with a special tag, which makes the protein attach to a surface in a highly specified way and ensures it remains functional.

The attachment occurs in a single step in just a few hours - unlike with existing techniques - and requires no prior chemical modification of the protein of interest or additional chemical steps.

Prof Jason Micklefield from the School of Chemistry, said: "DNA chips have revolutionised biological and medical science. For many years scientists have tried to develop similar protein chips but technical difficulties associated with attaching large numbers of proteins to surfaces have prevented their widespread application.

"The method we have developed could have profound applications in the diagnosis of disease, screening of new drugs and in the detection of bacteria, pollutants, toxins and other molecules."

Researchers from The University of Manchester are currently working as part of a consortium of several universities on a £3.1 million project which is aiming to develop so-called 'nanoarrays'.

These would be much smaller than existing 'micro arrays' and would allow thousands more protein samples to be placed on a single 'chip', reducing cost and vastly increasing the volume of data that could be simultaneously collected.

University of Manchester

---

---

	New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients by Lawrence T. Friedhoff (Author) Drug development, the processes by which a chemical compound becomes a “drug” and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and tactical considerations play out in an environment where a balance must be struck between the often-competing interests of the corporation, its investors, government regulators, and the safety and well being of intended patients. All the while, dwindling patent...
	The Emperor's New Drugs: Exploding the Antidepressant Myth by Irving Kirsch Ph.D. (Author) Irving Kirsch has the world doubting the efficacy of antidepressants. Based on fifteen years of research, The Emperor's New Drugs makes an overwhelming case that what the medical community considered a cornerstone of psychiatric treatment is little more than a faulty consensus. But Kirsch does more than just criticize: He offers a path society can follow to stop popping pills and start proper treatment.
	When Panic Attacks: The New, Drug-Free Anxiety Therapy That Can Change Your Life by David D. Burns M.D. (Author) Are you plagued by fears, phobias, or panic attacks? Do you toss and turn at night with a knot in your stomach, worrying about your job, your family, work, your health, or relationships? Do you suffer from crippling shyness, obsessive doubts, or feelings of insecurity? What you may not realize is that these fears are almost never based on reality. Anxiety is one of the world’s oldest cons. When you’re anxious, you’re actually fooling yourself. You are telling yourself things that simply aren’t true. See if you can recognize yourself in any of these distortions: All-or-Nothing Thinking: “My mind will go blank when I give my presentation at work, and everyone will think I’m an idiot.” Fortune Telling: “I just know I’ll freeze up and blow it when I take my...
	New Drug Development: A Regulatory Overview (New Drug Development ( Mathieu)) by Mark Mathieu (Author) Go inside the drug development and FDA regulatory process with today's most authoritative and popular reference on the topic. In its all-new 2008 edition, New Drug Development: A Regulatory Overview addresses the most cutting-edge developments redefining how new drugs are developed and regulated today, including: * How the FDA Amendments Act of 2007 will affect everything from drug reviews to postmarketing requirements. * How the CDER's efforts to integrate a culture of drug safety has affected the center's structure and its new drug review and approval processes. * How CDER's much-anticipated January 2008 transition to the eCTD as the only valid esubmission format will affect the FDA's drug submission and review process. * How the FDA and industry are already...
	Non-Drug Treatments for ADHD: New Options for Kids, Adults, and Clinicians by Richard P. Brown (Author), Patricia L. Gerbarg (Author) Safe and effective complementary treatments for managing ADD/ADHD.The prolific use of drugs to treat ADHD stirs heated debate in therapy and parenting circles today. Is this medication really going to improve my son’s symptoms? How best can I help my patient and her parents manage this difficult disorder? Will the side effects of this drug outweigh the benefits? What are my other options? Because ADHD affects every facet of life, from psychosocial development and peer relationships to family dynamics and academic and job performance, the need for better—that is, safer and more effective—treatments is urgent. Here, seasoned clinicians Pat Gerbarg and Richard Brown, known for providing the latest breakthroughs in integrative mental health treatments, draw on over 30...
	The Essential Guide to Prescription Drugs, A New Look at Cholesterol, Crestor, Lipitor, Livalo, Zocor by The Medicine Information Institute On sale for Kidney Month, a new update to the book that started information on medicines you don't need a PhD to understand. This new look at cholesterol tells the latest information on statin medicines that are associated with an increased risk of diabetes, tests you should talk to your doctor about, an herbal medicine that may lead to problems in combination and an enzyme that could help protect against side effects. More than 45 categories of information from benefits and risks to side effects, 9 important things to know and even possible benefits on sexual function.
	Harm Reduction Psychotherapy: A New Treatment for Drug and Alcohol Problems by Andrew Tatarsky (Editor) This ground-breaking volume provides readers with both an overview of harm reduction therapy and a series of ten case studies, treated by different therapists, that vividly illustrate this treatment approach with a wide variety of clients. Harm reduction is a framework for helping drug and alcohol users who cannot or will not stop completely—the majority of users—reduce the harmful consequences of use. Harm reduction accepts that abstinence may be the best outcome for many but relaxes the emphasis on abstinence as the only acceptable goal and criterion of success. Instead, smaller incremental changes in the direction of reduced harmfulness of drug use are accepted. This book will show how these simple changes in emphasis and expectation have dramatic implications for improving...
	Prescription Drugs: Alternative Uses, Alternative Cures: Over 1,500 New Uses for FDA-Approved Drugs by Kevin R. Loughlin (Author), Joyce Generali (Author) NEW BREAKTHROUGH TREATMENTS FOR Arthritis • Hay Fever • PMS • Depression Insomnia • Migraines • Chronic Heartburn High Blood Pressure • Ulcers Lyme Disease • Back Pain -- plus hundreds more Did You Know? • More than 1,500 legal prescription drugs have been shown by studies to be highly effective for uses not yet approved by the FDA. • One out of four prescriptions written today is for an alternative use of an FDA-approved drug. Off-label prescriptions -- as new uses for FDA-approved drugs are called -- are completely legal alternatives used by doctors on the cutting edge to treat illnesses and symptoms that do not respond to traditional therapy. But patients need to know what is available and safe in order to speak with their doctors about their health care...
	The Addiction Workbook: A Step-by-Step Guide for Quitting Alcohol and Drugs (New Harbinger Workbooks) by Patrick Fanning (Author) If you're thinking about quitting alcohol or drugs, this comprehensive workbook can help you get on track and reach your goals.The Addiction Workbook starts you on your journey by explaining the facts about addiction. It shows you how you can determine if you have a problem and helps you cut through denial or ambivalence to reach a clear decision to quit. Simple, concise exercises and tips help you gather support, deal with detoxification, improve nutrition, and build a personalized exercise program. You will discover how to relax without chemicals and cope with feelings of depression, anxiety, and anger.The book's final chapters cover conducting a personal moral inventory and making lifestyle changes to foster long-term relapse prevention.Direct and easy to understand, for those who want...